Intermediolateral Nucleus (Iml) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Intermediolateral Nucleus (IML) is a column of neurons located in the lateral horn of the spinal cord, spanning primarily the thoracic and upper lumbar segments (T1-L2). The IML is the primary site for sympathetic preganglionic neurons that control autonomic functions including heart rate, blood pressure, respiration, and pupillary dilation.
| Attribute |
Value |
| Cell Type |
Sympathetic Preganglionic Neurons |
| Location |
Spinal Cord Lateral Horn, T1-L2 |
| Morphology |
Multipolar, dendrites in lamina VII |
| Neurotransmitter |
Acetylcholine |
| Marker Genes |
ChAT, Phox2b, Sim1, RVR |
The IML is the central node for sympathetic nervous system control:
- Cardiovascular: Heart rate, contractility, vasoconstriction
- Respiratory: Bronchial tone, respiratory center modulation
- Pupillary: Pupillary dilation via superior cervical ganglion
- Sweat Glands: Sudomotor control
- Target: Peripheral autonomic ganglia
- Neurotransmitter: Acetylcholine (nicotinic receptors)
- Pathway: Spinal cord → preganglionic fiber → ganglion → postganglionic fiber
- Input: Visceral and somatic afferents, hypothalamic inputs
- Integration: Receives descending sympathetic commands
- Output: Sympathetic chain ganglia, collateral ganglia
¶ Morphology and Markers
- Soma Size: Medium to large (30-50 μm diameter)
- Dendritic Pattern: Dendrites extend into lamina VII
- Axon: Long preganglionic axons in white rami communicantes
- Organization: Columnar arrangement, segmentally repeated
- ChAT: Choline acetyltransferase - acetylcholine synthesis
- Phox2b: Transcription factor for autonomic neurons
- Sim1: Single-minded family bHLH transcription factor
- RVR: Related to VENs (Reticulospinal)
- Early Vulnerability: IML degeneration in MSA-C and MSA-P
- Mechanism: Autonomic failure due to preganglionic neuron loss
- Clinical Features: Orthostatic hypotension, bladder dysfunction
- Dysautonomia: IML involvement in PD autonomic dysfunction
- Mechanism: Lewy pathology in sympathetic preganglionic neurons
- Clinical Features: Orthostatic hypotension, constipation
- Respiratory Failure: IML contributes to respiratory control
- Mechanism: Motor neuron degeneration extends to autonomic regions
- Clinical Features: Respiratory insufficiency
- Selectivity: IML neurons selectively vulnerable
- Mechanism: Unknown, possibly protein aggregation
- Clinical Features: Severe orthostatic hypotension
| Gene |
Expression |
Function |
| ChAT |
High |
Acetylcholine synthesis |
| Phox2b |
High |
Autonomic neuron development |
| Sim1 |
High |
Sympathetic neuron identity |
| DBH |
Moderate |
Dopamine β-hydroxylase |
- Synaptic Proteins: For synaptic transmission
- Ion Channels: For rhythmic firing
- Metabolic Genes: High energy demand for continuous activity
| Target |
Approach |
Status |
| Spinal Cord Stimulation |
Modulate IML activity |
Research |
| Vagus Nerve Stimulation |
Autonomic regulation |
Approved |
| Deep Brain Stimulation |
Hypothalamic targets |
Research |
- Sympathomimetics: For orthostatic hypotension
- Noradrenaline Reuptake Inhibitors: Midodrine, droxidopa
- α2-Adrenergic Agonists: Clonidine modulation
- Single-Cell Sequencing: Characterizing IML neuron subtypes
- Circuit Mapping: Connectivity with brainstem and hypothalamus
- Optogenetics: Controlling sympathetic output
- Regeneration: Potential for cell replacement therapy
- Strack AM, et al. (1988). Organization of spinal sympathetic neurons. J Comp Neurol. PMID:3068282
- Llewellyn-Smith IJ, et al. (2015). Chemical phenotypes of sympathetic preganglionic neurons. Auton Neurosci. PMID:25982874
- Benarroch EE, et al. (2010). Autonomic dysfunction in neurodegenerative diseases. Clin Auton Res. PMID:20865632
- Kaufmann H, et al. (2020). Autonomic failure in MSA. Lancet Neurol. PMID:32891214
The study of Intermediolateral Nucleus (Iml) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Strack AM, et al. (1988) Organization of spinal sympathetic preganglionic neurons in the rat. J Comp Neurol. 268(4): 537-555.
- Llewellyn-Smith IJ, et al. (2015) Chemical phenotypes of sympathetic preganglionic neurons. Auton Neurosci. 192: 10-20.
- Benarroch EE, et al. (2010) Autonomic dysfunction in neurodegenerative diseases. Clin Auton Res. 20(4): 213-219.
- Kaufmann H, et al. (2020) Autonomic failure in multiple system atrophy. Lancet Neurol. 19(10): 852-861.
- Jänig W, et al. (2008) Spinal sympathetic interneurons: their pattern and organization. Prog Brain Res. 170: 151-163.
- Low PA, et al. (2018) Management of autonomic failure. Continuum (Minneap Minn). 24(2): 442-456.